Pulse-and-Cycle Peptide Management
Use peptides for defined periods, then reassess before receptors become desensitized.
- Difficulty
- Advanced
- Time to result
- ~ongoing to results
- Steps
- 5
- Confidence
- 96%
The pulse-and-cycle model treats peptides as purposeful interventions rather than permanent background additions. Before treatment, the clinician defines the problem, intended mechanism, expected result, and approximate review point. The peptide is then administered conservatively while outcomes and side effects are tracked. Because sustained exposure to hormones or peptides may lead cells to reduce receptor availability, the framework watches for declining response and pressure to increase the dose repeatedly. Planned pauses, wider intervals, or complete discontinuation can reveal whether the original need remains and may reduce unnecessary exposure. Foundational measures continue throughout, so the patient's progress does not depend exclusively on the peptide. The schedule is individualized rather than fixed, but it always includes a reassessment path and an off-ramp instead of an unexamined assumption of lifelong use.
Origin
Extracted from Habits & Hustle, where Dr. Tyna Moore explained how peptides were traditionally used in regenerative medicine and why she is cautious about continuous exposure.
Core principles
- 01Give every peptide a defined indication and treatment window.
- 02Pulse or cycle interventions instead of assuming lifelong continuous use.
- 03Preserve receptor sensitivity by avoiding relentless high exposure.
- 04Use off-periods to learn whether the intervention is still needed.
- 05Keep peptides inside a comprehensive protocol.
How to run it
- 1
Define the treatment window
State the condition or recovery objective, the mechanism being targeted, and the outcome that would justify stopping or changing treatment.
Pro tip Set an initial review date before the first dose.
Watch out Do not begin an open-ended intervention without a stopping rule.
- 2
Pulse conservatively
Use the lowest reasonable exposure and a schedule appropriate to the patient and peptide. Continue monitoring the rest of the protocol.
Pro tip Keep a simple record of dose, timing, symptoms, and objective outcomes.
Watch out Different peptides have different pharmacology and cannot share one universal cycling schedule.
- 3
Watch receptor-response signals
Look for fading benefits, new side effects, or a need for progressively higher doses to reproduce the same effect. Treat those patterns as reasons to reassess.
Pro tip Review adherence and changing health conditions before assuming the dose is inadequate.
Watch out Repeated escalation can deepen the very desensitization causing the declining response.
- 4
Create an off-period
When clinically appropriate, pause, reduce, or extend the interval and observe what happens. Maintain nutrition, movement, sleep, and other foundational measures.
Pro tip Choose an off-period long enough to produce interpretable observations.
Watch out Only interrupt prescription therapy with qualified medical supervision.
- 5
Restart only with a clear rationale
Resume treatment when the target problem returns or evidence shows that another course is justified. Recalculate the minimum effective exposure rather than returning automatically to the previous maximum.
Pro tip Treat each restart as a fresh prescribing decision.
Watch out Habitual restarting without reassessment turns cycling into disguised continuous use.
In the wild
A patient with a shoulder injury receives a peptide stack for a defined recovery period alongside rehabilitation and appropriate regenerative care. Once function and tissue tolerance improve, the peptides are stopped while the patient continues progressive loading.
→ Peptides support a recovery window without becoming an indefinite daily regimen.
Moore described cycling GLP-1 use around psoriasis and psoriatic-arthritis symptoms. How long she could remain off depended on food, workouts, sauna hygiene, sleep, travel, stress, and the season rather than a rigid universal calendar.
→ Treatment frequency changes in response to symptoms and surrounding lifestyle factors.
Common mistakes
Taking it forever by default
Continuous use without a review point makes it difficult to know whether the original problem still requires treatment.
Chasing adaptation with higher doses
Escalating repeatedly when effects fade can worsen receptor desensitization and increase risk.
Using a universal cycle
A fixed schedule such as four weeks on and one week off ignores the peptide, patient, purpose, and response.
Is it for you?
Best for
Clinicians supervising peptide use for time-bounded regenerative, metabolic, or recovery objectives.
Not ideal for
It does not override evidence-based continuous treatment requirements for conditions in which interruption would be unsafe.
From the transcript
“But we cycle them and we pulse them.”
“We want to go on them and come off of them. We want to use them as we need and come off of them, but…”
“And so we have to start using higher and higher doses. I don't like that cycle.”
From the episode
Episode 393: Dr. Tyna Moore: Why Ozempic Should Be Microdosed, HRT Tips, Peptides for Metabolic Health + More
Dr. Tyna Moore